Neuropsychiatric systemic lupus erythematosus with normal CSF and EEG: a diagnostic challenge in the setting of antiphospholipid syndrome and vasculitis

Tariq Aziz; Arvind Agrawal; Tanuja Manohar

doi:10.18203/2320-6012.ijrms20263561

Authors

Tariq Aziz Department of Medicine, N. K. P. Salve Institute of Medical Sciences and Research Center and Hospital, Digdoh Hills, Hingna, Nagpur, Maharashtra, India
Arvind Agrawal Department of Medicine, N. K. P. Salve Institute of Medical Sciences and Research Center and Hospital, Digdoh Hills, Hingna, Nagpur, Maharashtra, India
Tanuja Manohar Department of Medicine, N. K. P. Salve Institute of Medical Sciences and Research Center and Hospital, Digdoh Hills, Hingna, Nagpur, Maharashtra, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20263561

Keywords:

Neuropsychiatric systemic lupus erythematosus, NPSLE, Antiphospholipid syndrome, Seizures, Anti-dsDNA antibody, MRI brain, Cerebrospinal fluid, Immunotherapy, Vasculitis

Abstract

Neuropsychiatric systemic lupus erythematosus (NPSLE) is a diagnostically challenging manifestation of SLE. We report a 56-year-old woman with known SLE, antiphospholipid syndrome, vasculitis, and seizure disorder who presented with refractory seizures, hallucinations, and altered sensorium. Despite entirely normal cerebrospinal fluid (CSF) analysis and electroencephalography (EEG), MRI brain revealed an old microhemorrhage in the right thalamocapsular region with diffuse cerebral atrophy, and anti-dsDNA-NcX IgG was positive. A diagnosis of NPSLE was established on this basis. She was treated with intravenous immunoglobulin, intravenous dexamethasone, intravenous cyclophosphamide, and antiepileptic agents, achieving sustained clinical remission at three-month follow-up. This case highlights that normal CSF and EEG do not exclude NPSLE, and that serological and neuroimaging findings must be interpreted together to reach a timely diagnosis and initiate appropriate immunotherapy.

References

Hanly JG. ACR classification criteria for systemic lupus erythematosus: limitations and revisions to neuropsychiatric variables. Lupus. 2004;13(11):861-4.

Tektonidou MG, Varsou N, Kotoulas G, Antoniou A, Moutsopoulos HM. Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings. Arch Intern Med. 2006;166(20):2278-84.

Unterman A, Nolte JE, Boaz M, Abady M, Shoenfeld Y, Zandman-Goddard G. Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis. Semin Arthritis Rheum. 2011;41(1):1-11.

Arinuma Y, Yanagida T, Hirohata S. Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 2008;58(4):1130-5.

Barile-Fabris L, Ariza-Andraca R, Olguín-Ortega L, Jara LJ, Fraga-Mouret A, Miranda-Limón JM, et al. Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus. Ann Rheum Dis. 2005;64(4):620-5.

Magro-Checa C, Zirkzee EJ, Huizinga TW, Steup-Beekman GM. Management of neuropsychiatric systemic lupus erythematosus: current approaches and future perspectives. Drugs. 2016;76(4):459-83.

Govoni M, Bortoluzzi A, Padovan M, Silvagni E, Borrelli M, Donelli F, et al. The diagnosis and clinical management of the neuropsychiatric manifestations of lupus. J Autoimmun. 2016;74:41-72.

Appenzeller S, Cendes F, Costallat LTL. Epileptic seizures in systemic lupus erythematosus. Neurology. 2004;63(10):1808-12.

Hanly JG, Urowitz MB, Su L, Bae SC, Gordon C, Wallace DJ, et al. Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann Rheum Dis. 2010;69(3):529-35.

Schwartz N, Stock AD, Putterman C. Neuropsychiatric lupus: new mechanistic insights and future treatment directions. Nat Rev Rheumatol. 2019;15(3):137-52.

Zirkzee EJM, Huizinga TWJ, Bollen ELEM, van Buchem MA, Middelkoop HAM, van der Wee NJA, et al. Mortality in neuropsychiatric systemic lupus erythematosus (NPSLE). Lupus. 2014;23(1):31-8.